Tetanus Prophylaxis: Why Toxoid and Antitoxin Are Given at Separate Sites

For tetanus-prone wounds in patients with incomplete immunization, both tetanus toxoid (TT/Td/Tdap) and tetanus immune globulin (TIG) are administered simultaneously—but at different anatomic sites.

Mechanistic Rationale

• Tetanus Toxoid: Active immunization → stimulates endogenous antibody production (takes 1–2 weeks).
• TIG (Antitoxin): Passive immunization → provides immediate circulating anti-tetanospasmin antibodies (half-life ~3 weeks).

Interference Risk

If given at the same site, TIG antibodies can bind toxoid antigens locally, forming immune complexes that:

1. Block antigen presentation to APCs → blunted active response.
2. Accelerate toxoid clearance → reduced immunogenicity.

Standard Administration

• Toxoid: Deltoid (IM).
• TIG: Gluteus maximus or lateral thigh (IM), opposite side.
• Different syringes, different limbs.

Wound Management Algorithm

Immunization History	Clean/Minor Wound	Tetanus-Prone Wound
Unknown/<3 doses	TT + TIG	TT + TIG
≥3 doses, <5 yr	No booster	TT booster
≥3 doses, 5–10 yr	TT booster	TT booster
≥3 doses, >10 yr	TT booster	TT booster + TIG

TIG dose: 250 IU (adults/children) IM.